title: Rituximab in CD20 positive multiple myeloma.
authors.forename: J M
authors.initials: JM
authors.lastname: Bergua
authors.forename: C
authors.initials: C
authors.lastname: Cabrera
authors.forename: E G
authors.initials: EG
authors.lastname: Arteta
authors.forename: J
authors.initials: J
authors.lastname: Prieto
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D012074:Remission Induction; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab